Journal of Pharmacology and Pharmacotherapeutics

: 2021  |  Volume : 12  |  Issue : 3  |  Page : 115--119

Hurdles in mandatory generic medicine prescription

Verinder Jit Singh Virdi1, Money Gupta2, Rohit Gupta3 
1 Department of Pediatrics, Gian Sagar Medical College, Patiala, Punjab, India
2 Department of Surgery, Gian Sagar Medical College, Patiala, Punjab, India
3 Phd Student, Public Affairs Program, Woodrow Wilson School, Princeton University, USA

Correspondence Address:
Money Gupta
House No, 29, Sector 70, Mohali, Punjab

Coronavirus pandemic has brought forth the urgency of providing affordable health care to everyone. Generic medicines are often one-fourth to one-tenth of the cost of the branded drugs, and so offer a remarkable opportunity to significantly lower the health-care expenditure. However, the argument for promoting generic medicines is indisputable, we have to think about the other enabling conditions which are necessary for a successful health policy on encouraging generics without causing unintended adverse repercussions. This paper attempts to answer such questions by considering the motivations of the various stakeholders of the broader health services ecosystem in India and undertaking a systematic analysis of the winners and losers from such a policy. We argue that generic prescription will not be successful without prior improvement in the state capacity for quality control of drug manufacturing; rise in awareness among the doctors, patients, and pharmacists; improved trust in the medical systems; and innovative demand-side interventions.

How to cite this article:
Virdi VJ, Gupta M, Gupta R. Hurdles in mandatory generic medicine prescription.J Pharmacol Pharmacother 2021;12:115-119

How to cite this URL:
Virdi VJ, Gupta M, Gupta R. Hurdles in mandatory generic medicine prescription. J Pharmacol Pharmacother [serial online] 2021 [cited 2021 Nov 28 ];12:115-119
Available from:;year=2021;volume=12;issue=3;spage=115;epage=119;aulast=Virdi;type=0